In some cases, the protein levels decreased in late stage ovarian cancer relative to the healthy controls (e.g. NT-3 growth factor receptor, integrin alpha-1, stem cell factor, epidermal growth factor receptor (EGFR), and interleukin-8). This evidence concerns the gene NTRK3 and ovarian cancer.